Literature DB >> 33194066

CircHIPK3: a promising cancer-related circular RNA.

Yalu Zhang1, Qiaofei Liu1, Quan Liao1.   

Abstract

Circular RNA (circRNA) is a special type of endogenous noncoding RNAs (ncRNAs), and are characterized by a covalently closed loop structure without a 5' cap and poly-adenylated tails. Abnormal expression of circRNAs has been implicated in a wide range of human cancers, where they function as either tumor suppressor genes or oncogenes. CircHIPK3, circRNA homeodomain-interacting protein kinase 3, is associated with human cancers such as lung cancer, bladder cancer, hepatocellular carcinoma, colorectal cancer, osteosarcoma, glioma and prostate cancer, et al. Numerous studies have indicated that circHIPK3 functions as a miRNA sponge to regulate the target genes and exert specific biological effects, including regulation of cell proliferation, invasion, and migration. Furthermore, circHIPK3 is thought to be a novel diagnostic biomarker, therapeutic target, and prognostic biomarker in different cancer types. Here, we reviewed the recent progress of the mechanism and functions of circHIPK3 during the evolution of malignancies. AJTR
Copyright © 2020.

Entities:  

Keywords:  Circular RNA; HIPK3; cancer; microRNA sponge

Year:  2020        PMID: 33194066      PMCID: PMC7653572     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  60 in total

Review 1.  Regulation of circRNA biogenesis.

Authors:  Ling-Ling Chen; Li Yang
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

2.  Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.

Authors:  W-G Liu; Q Xu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-09       Impact factor: 3.507

3.  CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.

Authors:  Zhaoyang Ke; Fei Xie; Chaopan Zheng; Daishi Chen
Journal:  J Cell Physiol       Date:  2018-08-02       Impact factor: 6.384

4.  CircHIPK3 promotes colorectal cancer cells proliferation and metastasis via modulating of miR-1207-5p/FMNL2 signal.

Authors:  Yan Yan; Meng Su; Baoli Qin
Journal:  Biochem Biophys Res Commun       Date:  2020-02-08       Impact factor: 3.575

Review 5.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Authors:  Sebastien Antoni; Jacques Ferlay; Isabelle Soerjomataram; Ariana Znaor; Ahmedin Jemal; Freddie Bray
Journal:  Eur Urol       Date:  2016-06-28       Impact factor: 20.096

6.  Exosomal circRNAs: new players in the field of cholangiocarcinoma.

Authors:  Corentin Louis; Matthis Desoteux; Cédric Coulouarn
Journal:  Clin Sci (Lond)       Date:  2019-11-15       Impact factor: 6.124

7.  Short intronic repeat sequences facilitate circular RNA production.

Authors:  Dongming Liang; Jeremy E Wilusz
Journal:  Genes Dev       Date:  2014-10-03       Impact factor: 11.361

8.  Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.

Authors:  Qiupeng Zheng; Chunyang Bao; Weijie Guo; Shuyi Li; Jie Chen; Bing Chen; Yanting Luo; Dongbin Lyu; Yan Li; Guohai Shi; Linhui Liang; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Nat Commun       Date:  2016-04-06       Impact factor: 14.919

9.  Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.

Authors:  Yuanfeng Zeng; Huijun Xie; Yudan Qiao; Jianmei Wang; Xiling Zhu; Guoyang He; Yuling Li; Xiaoli Ren; Feifei Wang; Li Liang; Yanqing Ding
Journal:  Cancer Sci       Date:  2015-10       Impact factor: 6.716

10.  circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma.

Authors:  Genwen Chen; Yanting Shi; Mengmeng Liu; Jianyong Sun
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

View more
  13 in total

Review 1.  Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.

Authors:  Qian Bai; Zhenjie Pan; Ghulam Nabi; Farooq Rashid; Yang Liu; Suliman Khan
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Emerging landscape of circHIPK3 and its role in cancer and other diseases (Review).

Authors:  Qi Shao; Yong Huang; Cai Zhang; Xiaochan Gao; Shiyang Gao
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

Review 3.  Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer.

Authors:  Consuelo Pitolli; Alberto Marini; Claudio Sette; Vittoria Pagliarini
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

4.  Hsa_circ_0041268 promotes NSCLC progress by sponging miR-214-5p/ROCK1.

Authors:  Wenhui Yang; Lina Wu; Mingming Jin
Journal:  J Clin Lab Anal       Date:  2022-02-25       Impact factor: 2.352

5.  Association of has_circ_0001944 upregulations with prognosis and cancer progression in patients with colorectal cancer.

Authors:  He Duan; Jian Qiu
Journal:  Discov Oncol       Date:  2022-04-09

6.  Dysregulation of the miR-30c/DLL4 axis by circHIPK3 is essential for KSHV lytic replication.

Authors:  Katherine L Harper; Timothy J Mottram; Chinedu A Anene; Becky Foster; Molly R Patterson; Euan McDonnell; Andrew Macdonald; David Westhead; Adrian Whitehouse
Journal:  EMBO Rep       Date:  2022-03-03       Impact factor: 9.071

7.  CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis.

Authors:  Weifeng He; Xiangqi Zhou; Yini Mao; YangJie Wu; Xiyang Tang; Sijia Yan; Sanyuan Tang
Journal:  Eur J Med Res       Date:  2022-04-28       Impact factor: 4.981

8.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

9.  Silencing of circHIPK3 hampers platelet-derived growth factor-induced proliferation and migration in airway smooth muscle cells through the miR-375/MMP-16 axis.

Authors:  Yu Jiang; Xiaoqing Guo; Junhong Qin
Journal:  Cytotechnology       Date:  2021-07-04       Impact factor: 2.040

10.  Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286.

Authors:  Jun Ni; Xun Xi; Sujian Xiao; Xigang Xiao
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.